About this trial
This study investigates the effects of foods enriched with alternative protein sources, including edible insects, microalgae, hemp, and legumes, on appetite regulation, satiety, food preferences, and metabolic health in healthy adults and individuals with overweight. The study is part of the CIPROMED project, which aims to support sustainable and circular food systems in the Mediterranean area.
The study consists of two phases. In the acute phase, participants will consume different protein-enriched bread products in a controlled setting following a randomized crossover design. Each participant will be exposed to multiple test conditions, allowing within-subject comparisons of postprandial responses. Outcomes assessed during this phase include satiety, hunger, food preference, craving, and short-term energy intake, measured using validated scales and dietary assessment tools.
In the chronic phase, participants will follow structured dietary interventions over a longer period within a Mediterranean dietary framework. Participants will be assigned to different dietary patterns including alternative protein-based foods and control products. This phase aims to evaluate the effects of repeated consumption of alternative protein sources on metabolic parameters, gastrointestinal tolerance, nutritional status, and behavioral responses.
The study aims to assess the acceptability and physiological effects of alternative protein sources and to compare their impact with that of traditional protein sources commonly used in Mediterranean diets.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Providing signed informed consent,
Being between 18 and 65 years of age,
Having a body mass index (BMI) within the normal range, defined as between 18.5 and 24.9 kg/m² or Having a body mass index (BMI) between 25.0 and 34.9 kg/m², inclusive, corresponding to the overweight category or, at most, class I obesity.
Disqualifiers
Positive and documented history of allergy to legumes, insects, microalgae, shellfish, mollusks, crustaceans, snails, insect venom, house dust mites, or any component (ingredient or additive) present in the food prototypes tested, or a confirmed or suspected diagnosis of Celiac Disease.
History of severe allergic reactions to any type of allergen.
Pregnancy or Breastfeeding
Trial design
Crossover
Treatments tested in this trial
Mediterranean Diet with Control Products (chronic phase)
Other interventionMediterranean diet including control foods such as legume-based bread and standard fish burger, consumed five times per week for a period of 2 months.
Mediterranean Diet with Insect Protein Bread (chronic phase)
Other interventionMediterranean diet including bread enriched with edible insect protein (Acheta domesticus), consumed five times per week over a 2-month intervention period.
Mediterranean Diet with Seaweed-Based Burger (chronic phase)
Other interventionMediterranean diet including a burger made from edible seaweed, consumed five times per week over a 2-month intervention period.
Treatment groups
Trial outcomes
Primary outcomes
Postprandial Satiety Assessed by Visual Analogue Scales (VAS)
Subjective appetite sensations are assessed using a customized 100 mm Visual Analogue Scale (VAS). The scale evaluates four primary domains: hunger, fullness (satiety), desire to eat, and prospective food consumption. Participants mark a point on a 100 mm line anchored by "not at all" (0 mm) and "extremely" (100 mm). Total scores for each domain range from 0 to 100, where higher scores for satiety indicate a greater feeling of fullness, and higher scores for hunger indicate a greater urge to eat. Post-prandial ratings are measured at baseline and at specific intervals following the consumption of protein-enriched bread products.
Food Preference and Craving Responses Assessed by HTAS, LFP, and Hedonic Scale
Food preference, motivation, and attitudes were assessed following consumption of different protein-enriched bread products using three distinct validated instruments: Health and Taste Attitude Scales (HTAS): The validated Italian version of the HTAS was used to evaluate psychological attitudes toward food. The questionnaire comprises six subscales divided into two dimensions: Health-related attitudes (General health interest, Light product interest, Natural product interest) and Taste-related attitudes (Craving for sweet foods, Pleasure orientation, Using food as a reward). 9-Point Hedonic Scale: Sensory liking of the test foods was evaluated using a 9-point scale ranging from 1 ('Extremely unpleasant') to 9 ('Extremely pleasant'). Leeds Food Preference Questionnaire (LFP): This psychometric tool was used to assess food motivation via food images. It measures two distinct components: 'Liking' (perceived pleasantness) and 'Wanting' (motivation to consume the food at testing).
Fasting Blood Glucose
Fasting plasma glucose concentration, assessed following the dietary intervention with alternative protein sources. Unit of Measure: mg/dL
Fasting Serum Insulin
Fasting serum insulin concentration measured following dietary interventions with alternative protein sources. Unit of Measure: µIU/mL.
Secondary outcomes
Postprandial Energy Intake and Energy Compensation Assessed by 24-Hour Dietary Recall
Postprandial energy intake and energy compensation measured using 24-hour dietary recall following consumption of different protein-enriched bread products.
Incidence of Adverse Events
Participants will complete a 72-hour recall questionnaire to document any adverse reactions they may have experienced following product consumption.
Liver Fat Content and Hepatic Stiffness Assessed by FibroScan and Controlled Attenuation Parameter (CAP)
Liver fat content and hepatic stiffness measured using transient elastography (FibroScan) and Controlled Attenuation Parameter (CAP) to evaluate changes following dietary interventions with different protein sources.
Gut Microbiota Composition
Gut microbiota composition assessed through analysis of fecal samples to evaluate changes following dietary interventions with different protein sources.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Bologna
Lead sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Collaborator
University of Turin, Italy
Collaborator
Azienda Usl di Bologna
Collaborator